https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Presents-Praliciguat-Phase-IIa-Study-Data-Showing-Positive-Impact-on-Metabolic-and-Cardiovascular-Clinical-Endpoints-at-the-American-Diabetes-Associations-78th-Scientific-Sessions/default.aspx